RecallDepth
Class II Terminated

Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in (a) 150 mL bottle (NDC 0093-4150-80) (b) 80 mL bottle (NDC 0093-4150-79), Rx Only, Manufactured in Canada By: Teva Canada Limited Toronto, Canada, M1B2K9, Manufactured For: Teva Pharmaceuticals USA, INC. North Wales, PA 19454.

This recall has been terminated (originally issued April 24, 2019).

Company
Teva Pharmaceuticals Usa
Recall Initiated
April 12, 2019
Posted
April 24, 2019
Recall Number
D-1205-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
171,488 150 mL and 80 mL bottles
Firm Location
North Wales, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

Subpotent Product: assay results for Amoxicillin were below the specification limits.

Distribution

Nationwide in the USA and Puerto Rico

Lot / Code Info

Lots: (a) Lot # 35436769A, exp. date 05/2019; 35438389A, 35438390A, exp. date 01/2020; 35440838A, exp. date 10/2020; (b) 35437491A, 35443574B, exp. date 09/2021

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls